Sweden-wide study links substance-use disorders to markedly higher suicide risk; genetic overlap suggested

The Conversation reports on a large Swedish epidemiological study that examines suicidal behaviour among people with substance-use disorders (SUD) using national registers. The study analysed records for just over 4.2 millionSwedish-born individuals (1958–1999) from 1973 to 2020, defining suicidal behaviour as a suicide attempt or death by suicide. Among 258,046 people with an SUD, 23% had recorded suicidal behaviour versus 1.5% without an SUD. The risk remained after adjusting for sex, birth year, socioeconomic status, and co-occurring psychiatric conditions, with an overall sixfold increase in risk. The researchers also explored familial clustering, finding stronger associations when relatives were more closely related, suggesting shared genetic influences. The article notes limitations, practical implications for clinicians, and the need for integrated suicide prevention in addiction care. Author: The Conversation.

Overview of the Swedish data

The article summarizes a Nature Communications study that used Sweden’s national registers to examine suicidal behaviour among people with substance-use disorders (SUD). The researchers analysed data from just over 4.2 million individuals born in Sweden between 1958 and 1999, with records spanning 1973 to 2020. Suicidal behaviour was defined as either a recorded suicide attempt or death by suicide. The registers’ scope, including diagnoses, causes of death, and family relationships, provided a unique opportunity to explore patterns at a population level and across families.

Major findings on risk and substance-type patterns

Among the 258,046 people with a substance-use disorder, 23% had a recorded suicide attempt or death by suicide, compared with 1.5% of those without an SUD. The risk varied by specific disorders: 13.6% for alcohol use disorder, 26% for drug use disorder, and 44.4% for those diagnosed with both alcohol and drug use disorders. The authors emphasize that these figures reflect hospital and specialist outpatient diagnoses and likely reflect more severe cases than in the general population, so they should not be interpreted as representative of all individuals with SUD.

Context and limitations

The study acknowledges that primary care diagnoses were not comprehensively captured, which may bias toward more severe substance-use problems. It also notes that population-level data cannot determine causality between SUD and suicidal behaviour. Nevertheless, the associations observed align with prior Swedish research showing elevated suicide risk across substance-use disorders and support the idea of overlapping vulnerabilities between SUD and suicidal crises.

Co-occurring mental health conditions

Depression, anxiety disorders, bipolar disorder and ADHD were more common among people with SUD who had experienced suicidal behaviour, indicating that comorbidity contributes to risk and should inform clinical assessments and interventions.

Risk after adjustment and familial patterns

Even after statistical adjustment for sex, birth year, socioeconomic status, and co-occurring psychiatric conditions, individuals with a substance-use disorder had more than six times the risk of a recorded suicide attempt or death by suicide compared with those without a SUD. The researchers also explored relatives, comparing cousins, half-siblings, full siblings, and twins. The more closely related the relative, the stronger the association, suggesting shared genetic and environmental factors contribute to the overlap between SUD and suicidal behaviour. Prior Swedish family and twin data have similarly reported shared genetic influences between these outcomes.

Practical implications for clinicians and families

The findings offer actionable guidance for healthcare providers: a family history of substance-use disorders, particularly in close relatives, may provide valuable additional information when assessing suicide risk. People with both alcohol and drug-use disorders showed the highest proportion of suicidal behaviour, highlighting a need for targeted vigilance in this subgroup. The article also underscores a gap in treatments specifically designed to reduce suicidal behaviour in people with SUD and highlights a 2020 review that found only six randomized trials, with evidence not yet sufficient to confirm effectiveness. There is a call for integrating suicide prevention into addiction care, including asking about suicidal thoughts and past attempts, recognizing co-occurring mental health conditions, and ensuring access to psychiatric support.

Broader context and conclusions

Genes likely influence risk rather than determine destiny; family circumstances and individual experiences also shape outcomes. Understanding the genetic overlap with suicidal behaviour could help identify at-risk individuals earlier and guide conversations about family history with healthcare professionals. While population studies cannot explain individual deaths, they help identify groups at higher risk and inform where prevention resources are most urgently needed. Original publisher: The Conversation.